{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:38:46Z","timestamp":1790617126397,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier","isbn-type":[{"value":"9780128117385","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.pbr.2016.12.011","type":"book-chapter","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T13:01:35Z","timestamp":1487854895000},"page":"227-261","source":"Crossref","is-referenced-by-count":29,"title":["From open to large-scale randomized cell transplantation trials in Huntington's disease"],"prefix":"10.1016","author":[{"given":"Anne-Catherine","family":"Bachoud-L\u00e9vi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2016.12.011_bb0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0035-3787(06)75065-2","article-title":"Intracerebral graft in Huntington disease: debates and prospects","volume":"162","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1474-4422(09)70278-9","article-title":"Neural grafts in Huntington's disease: viability after 10 years","volume":"8","author":"Bachoud-L\u00e9vi","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.neurol.2014.10.007","article-title":"Regenerative medicine in Huntington's disease: current status on fetal grafts and prospects for the use of pluripotent stem cell","volume":"170","author":"Bachoud-L\u00e9vi","year":"2014","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/exnr.1999.7239","article-title":"Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease","volume":"161","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0025","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after intracerebral transplantation","volume":"356","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0030","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.56.8.1052","article-title":"Retest effects and cognitive decline in longitudinal follow-up of patients with early HD","volume":"56","author":"Bachoud-L\u00e9vi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mds.10117","article-title":"Fetal neural grafts for Huntington's disease: a prospective view","volume":"17","author":"Bachoud-L\u00e9vi","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pneurobio.2013.04.003","article-title":"Scientific and ethical issues related to stem cell research and interventions in neurodgenerative disorders of the brain","volume":"110","author":"Barker","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease","volume":"84","author":"Barker","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/hum.2004.15.968","article-title":"Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study","volume":"15","author":"Bloch","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0065","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000098933.34804.FC","article-title":"Understanding of informed consent by demented individuals","volume":"61","author":"Buckles","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0070","first-page":"661","article-title":"Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation","volume":"160","author":"Capetian","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0075","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.24174","article-title":"Mutant huntingtin is present in neuronal grafts in Huntington disease patients","volume":"76","author":"Cicchetti","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/aws359","article-title":"Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability","volume":"136","author":"Cisbani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128209","article-title":"Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting","volume":"10","author":"Cleret De Langavant","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0095","series-title":"46.402 Definitions","article-title":"Effective July 14, 2009. Part 46 Protection of Human Subjects","author":"Code of Federal Regulations","year":"2009"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mds.24062","article-title":"Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease","volume":"27","author":"Cubo","year":"2012","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/bs.pbr.2016.12.011_bb9000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161106","article-title":"French speaking Huntington group. Comt Val158met polymorphism modulates Huntington's disease progression","volume":"11","author":"De Diego-Balaguer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.neuroscience.2005.01.016","article-title":"Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease","volume":"132","author":"Dobrossy","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0110","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","article-title":"Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study","volume":"32","author":"Douaud","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0115","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuroimage.2009.03.044","article-title":"In vivo evidence for the selective subcortical degeneration in Huntington's disease","volume":"46","author":"Douaud","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0079-6123(00)27017-9","article-title":"The integration and function of striatal grafts","volume":"127","author":"Dunnett","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/qjmed\/hcn067","article-title":"Recall of informed consent information by healthy volunteers in clinical trials","volume":"101","author":"Fortun","year":"2008","journal-title":"QJM"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199909233411311","article-title":"Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease","volume":"341","author":"Freeman","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0140","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2010.08.031","article-title":"Technical factors that influence neural transplant safety in Huntington's disease","volume":"227","author":"Freeman","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.20564","article-title":"Positron emission tomography after fetal transplantation in Huntington's disease","volume":"58","author":"Furtado","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2008.06.003","article-title":"Development of human striatal anlagen after transplantation in a patient with Huntington's disease","volume":"213","author":"Gallina","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2009.12.005","article-title":"Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation","volume":"222","author":"Gallina","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000360583","article-title":"Human striatum remodeling after neurotransplantation in Huntington's disease","volume":"92","author":"Gallina","year":"2014","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(12)70064-9","article-title":"Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations","volume":"11","author":"Galpern","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington's disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/stem.772","article-title":"The role of human leukocyte antigen matching in the development of multiethnic \u201chaplobank\u201d of induced pluripotent stem cell lines","volume":"30","author":"Gourraud","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/CS20050148","article-title":"Pharmaceutical, cellular and genetic therapies for Huntington's disease","volume":"110","author":"Handley","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"issue":"58","key":"10.1016\/bs.pbr.2016.12.011_bb0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington's disease","volume":"12","author":"Hauser","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0195","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/01.WNL.0000098878.47789.BD","article-title":"Profile of cognitive progression in early Huntington's disease","volume":"61","author":"Ho","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: reliability and consistency","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0205","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1460-9568.2002.01959.x","article-title":"Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS","volume":"15","author":"Hurelbrink","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0210","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.stem.2008.11.009","article-title":"New ISSCR guidelines underscore major principles for responsible translational stem cell research","volume":"3","author":"Hyun","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0b013e3182a05ba5","article-title":"Cognitive impairment and PD patients' capacity to consent to research","volume":"81","author":"Karlawish","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0220","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","article-title":"Neural transplantation in Huntington disease: long-term grafts in two patients","volume":"68","author":"Keene","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exnr.1997.6685","article-title":"Safety of intrastriatal neurotransplantation for Huntington's disease patients","volume":"149","author":"Kopyov","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1759-1961.2011.00018.x","article-title":"Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington' s disease: consequences for cerebral transplantation programs","volume":"2","author":"Krebs","year":"2011","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000166","article-title":"Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease","volume":"2","author":"Krystkowiak","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2003.10.010","article-title":"Rapid decline in motor symptoms in HD neural transplant patients prior to surgery","volume":"63","author":"Lazic","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0250","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/mds.20966","article-title":"Electrophysiological deterioration over time in patients with Huntington's disease","volume":"21","author":"Lefaucheur","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"Lewitt","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0260","doi-asserted-by":"crossref","first-page":"20140370","DOI":"10.1098\/rstb.2014.0370","article-title":"Treatment of Parkinson's disease using cell transplantation","volume":"370","author":"Lindvall","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0265","first-page":"259","article-title":"Stereotactic planning software for human neurotransplantation: suitability in 22 surgical cases of Huntington's disease","volume":"32","author":"Lopez","year":"2014","journal-title":"Restor. Neurol. Neurosci."},{"issue":"7560","key":"10.1016\/bs.pbr.2016.12.011_bb0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0275","first-page":"109","article-title":"The first homotopic fetal homograft of the striatum in the treatment of Huntington's disease","volume":"129","author":"Madrazo","year":"1993","journal-title":"Gac. Med. Mex."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0280","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01616412.1995.11740334","article-title":"Fetal striatal homotransplantation for Huntington's disease: first two case reports","volume":"17","author":"Madrazo","year":"1995","journal-title":"Neurol. Res."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0285","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3171\/jns.1998.89.4.0592","article-title":"Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease","volume":"89","author":"Mamelak","year":"1998","journal-title":"J. Neurosurg."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0290","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0295","series-title":"PLoS Curr.","article-title":"Large-sized fetal striatal grafts in Huntington's disease do stop growing: long-term monitoring in the Florence experience","author":"Mascalchi","year":"2014"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0300","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3171\/jns.2000.92.3.0493","article-title":"Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note","volume":"92","author":"Mendez","year":"2000","journal-title":"J. Neurosurg."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0310","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jnnp-2013-306533","article-title":"Fetal striatal grafting slows motor and cognitive decline of Huntington's disease","volume":"85","author":"Paganini","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0315","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1523\/JNEUROSCI.3706-05.2006","article-title":"Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421","volume":"26","author":"Pardo","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0320","first-page":"273","article-title":"Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease","volume":"68","author":"Peschanski","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0963-6897(97)00028-6","article-title":"Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations","volume":"6","author":"Philpott","year":"1997","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0330","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3727\/096368913X676222","article-title":"Donor-specific anti-HLA antibodies in Huntington's disease recipients of human fetal striatal grafts","volume":"24","author":"Porfirio","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mds.870110205","article-title":"Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD)","volume":"11","author":"Quinn","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0340","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","article-title":"Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease","volume":"79","author":"Reuter","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0345","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1492(199906)12:4<221::AID-NBM582>3.0.CO;2-Q","article-title":"In vivo magnetic resonance spectroscopy of human fetal neural transplants","volume":"12","author":"Ross","year":"1999","journal-title":"NMR Biomed."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0350","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0355","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-444-59575-1.00016-8","article-title":"Clinical trials of neural transplantation in Huntington's disease","volume":"200","author":"Rosser","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0360","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0365","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/fcp.12077","article-title":"The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials","volume":"28","author":"Salem","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0370","doi-asserted-by":"crossref","first-page":"e0145842","DOI":"10.1371\/journal.pone.0145842","article-title":"How to capitalize on the retest effect in future trials on Huntington's disease","volume":"10","author":"Schramm","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1355617701711046","article-title":"Longitudinal evaluation of cognitive disorder in Huntington's disease","volume":"7","author":"Snowden","year":"2001","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000098976","article-title":"Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea","volume":"58","author":"Sramka","year":"1992","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0395","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2016.12.011_bb0400","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3727\/096368914X685429","article-title":"Translation of cell therapies to the clinic: characteristics of cell suspensions in large-diameter injection cannulae","volume":"24","author":"Torres","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.12.011_bb0405","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/MOT.0000000000000344","article-title":"Indications and prospects of neural transplantation for chronic neurological diseases","volume":"21","author":"Vadori","year":"2016","journal-title":"Curr. Opin. Organ Transplant."}],"container-title":["Progress in Brain Research","Functional Neural Transplantation IV - Translation to Clinical Application, Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612316301832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612316301832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T23:22:15Z","timestamp":1536016935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612316301832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128117385"],"references-count":82,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2016.12.011","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}